US Department of Veterans Affairs
Customers
0
None disclosed
Suppliers
1
1 active
Latest period
Dec 31, 2025
10-K filed 2026-02-26
Suppliers 1
Companies that disclose US Department of Veterans Affairs as a major customer, as a share of their own revenue. 1 active, 0 lapsed.
| Company | % of their revenue | Est. $ from US Department of Veterans Affairs | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| PSNL Personalis, Inc. |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-02-26 |
Multiple customers have provided more than 10% of total revenue in the periods presented, or accounted for more than 10% of accounts receivable at each respective balance sheet date, as follows: Revenue Accounts Receivable Year Ended December 31, December 31, 2025 2024 2025 2024 Moderna, Inc. 22% 28% * * VA MVP 17% * * * US Department of Veterans Affairs * * 24% * Merck & Co., Inc. * * 12% 31% AstraZeneca UK Ltd * * 10% * Pfizer Inc. * * * 25% Natera, Inc. * 30% * 13% * Less than 10% of revenue or accounts receivableRevenue RecognitionThe Company applies the revenue recognition guidance in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, (“ASC Topic 606”).The Company derives revenue from the sale of genomic testing services. | ||||||
Alerts are coming
Get an email when US Department of Veterans Affairs's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.